Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting

BACKGROUND: Given the high prevalence of cognitive impairment in Parkinson’s disease (PD), cognitive screening is important in clinical practice. The Montreal Cognitive Assessment (MoCA) is a frequently used screening test in PD to detect mild cognitive impairment (PD-MCI) and Parkinson’s disease de...

Descripción completa

Detalles Bibliográficos
Autores principales: Fengler, Sophie, Kessler, Josef, Timmermann, Lars, Zapf, Alexandra, Elben, Saskia, Wojtecki, Lars, Tucha, Oliver, Kalbe, Elke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954721/
https://www.ncbi.nlm.nih.gov/pubmed/27437705
http://dx.doi.org/10.1371/journal.pone.0159318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954721/
https://www.ncbi.nlm.nih.gov/pubmed/27437705
http://dx.doi.org/10.1371/journal.pone.0159318

Ejemplares similares